The grand scheme of things
Read Time: 6 mins
Written By:
Felicia Riney, D.B.A.
Martin Shkreli, 34, a former pharmaceutical executive who became famous by inflating life-saving drug prices, has been sentenced to seven years in prison. His fraud convictions were related to his involvement with Retrophin, the pharmaceutical company he founded in 2011, and two hedge funds he ran. (See Martin Skrekli Sentenced to 7 Years in Prison for Fraud, by Stephanie Clifford, The New York Times, March 9.)
Known by the moniker, “Pharma Bro,” Shkreli is best known for raising the price of a drug, Daraprim, by 5,000 percent. He founded Retrophin in 2011 and prosecutors say he lied to his investors about how well their hedge funds were doing. According to the article, Shkreli’s scheme cost investors more than $10 million. But that’s nothing compared to his overall worth — $27.2 million. Shkreli also must forfeit $7.36 million.
Unlock full access to Fraud Magazine and explore in-depth articles on the latest trends in fraud prevention and detection.
Read Time: 6 mins
Written By:
Felicia Riney, D.B.A.
Read Time: 7 mins
Written By:
Patricia A. Johnson, MBA, CFE, CPA
Read Time: 12 mins
Written By:
Roger W. Stone, CFE
Read Time: 6 mins
Written By:
Felicia Riney, D.B.A.
Read Time: 7 mins
Written By:
Patricia A. Johnson, MBA, CFE, CPA
Read Time: 12 mins
Written By:
Roger W. Stone, CFE